Citation Impact
Citing Papers
Thyroid and adrenal axis in major depression: a controlled study in outpatients
2005
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
2015 Standout
Hypothalamo–pituitary–adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects
1999
Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study
2019
Free radicals, antioxidants and functional foods: Impact on human health
2010 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Inflammation: the link between insulin resistance, obesity and diabetes
2003 Standout
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
1995
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
1997 StandoutNature
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
The angiotensin converting enzyme I/D polymorphism in Russian athletes
2001
Oxytocin Improves “Mind-Reading” in Humans
2006 Standout
Cushing's syndrome
2015 Standout
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
1993
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
1995 Standout
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
The mechanisms of action of metformin
2017 Standout
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Endogenous opiates: 1999
2000
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
Inflammation, stress, and diabetes
2005 Standout
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
2014
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
2016
Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats
1996
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Influence of nitric oxide on hypoglycemia - or angiotensin II-stimulated ACTH and GH secretion in normal men
1996
Adipokines in inflammation and metabolic disease
2011 Standout
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women
2009
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Type 2 diabetes
2017 Standout
Timing of Pubertal Maturation in Girls: An Integrated Life History Approach.
2004 Standout
Narcolepsy in orexin Knockout Mice
1999 Standout
Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus
2006
THE ENDOCRINOLOGY OF OBESITY
1996
The stress system in the human brain in depression and neurodegeneration
2005
Melatonin, endocrine pancreas and diabetes
2007
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
1997 Standout
Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients
1989
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
ACTN3 Genotype Is Associated with Human Elite Athletic Performance
2003 Standout
Oxytocin in the human--regulation of derivations and destinations
1997
Cushing's syndrome
2006 Standout
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
2005 Standout
Ghrelin: Structure and Function
2005 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
The molecular neurobiology of depression
2008 StandoutNature
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
The lateral hypothalamic area revisited: Neuroanatomy, body weight regulation, neuroendocrinology and metabolism
1993
Gut microbiota in human metabolic health and disease
2020 Standout
Vasopressin and Oxytocin in Stressa
1995
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Stressor Specificity of Central Neuroendocrine Responses: Implications for Stress-Related Disorders
2001
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
2016
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Nonalcoholic Fatty Liver Disease
2001 Standout
CHOLINERGIC MUSCARINIC RECEPTOR BLOCKADE WITH PIRENZEPINE ABOLISHES SLOW WAVE SLEEP‐RELATED GROWTH HORMONE RELEASE IN NORMAL ADULT MALES
1986
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
2015
The Relationship between Smoking Status and Cortisol Secretion
2006
Understanding Adipocyte Differentiation
1998 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Effects of a single dose of N-Acetyl-5-methoxytryptamine (Melatonin) and resistance exercise on the growth hormone/IGF-1 axis in young males and females
2007
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Central nervous system actions of oxytocin and modulation of behavior in humans
1997
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
2010 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine (“ecstasy”): is metabolism a contributory factor?
2001
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
1996 StandoutScience
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
LACK OF EFFECT OF MUSCARINIC CHOLINERGIC BLOCKADE ON THE GH RESPONSES TO GRF 1–29 AND TRH IN ACROMEGALIC SUBJECTS
1986
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of L. Capretti being referenced
Different effects of naloxone on the growth hormone response to melatonin and pyridostigmine in normal men
1998
Oxytocin Does not Modify Glucagon- or Calcitonin-Induced ACTH-Cortisol Rise in Humans
1989
Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects
1990
Increase by naloxone of arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in obese men
1990
Oxytocin response to challenging stimuli in elderly men
1994
Luteinizing hormone responses to gonadotropin-releasing hormone and naloxone in menstruating women with type I diabetes of different duration
1991
Reduction of Baclofen-, but not Sodium Valproate-Induced Growth Hormone Release in Type I Diabetic Men
1991
Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men
1994
Intravenously infused substance P enhances basal and growth hormone (GH) releasing hormone-stimulated GH secretion in normal men
1992
Altered Neuroendocrine Control of GH Secretion in Normal Women of Advanced Reproductive Age
1997
Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men
1997
Stimulation of ACTH and GH release by angiotensin II in normal men is mediated by the AT1 receptor subtype
1998
Inhibitory effect of dexamethasone on the oxytocin response to insulin-induced hypoglycemia in normal men
1992
Serotonergic control of TSH and PRL secretion in obese men
1990
Stimulation of ACTH/Cortisol by Intravenously Infused Substance P in Normal Men: Inhibition by Sodium Valproate
1992
Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis
1998
Influence of thyroid status on the paradoxical growth hormone response to thyrotropin-releasing hormone in human obesity
1994
Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa
1991
Desmopressin and hexarelin tests in alcohol‐induced pseudo‐Cushing’s syndrome
2000
Mediation by nitric oxide of LH-RH-stimulated gonadotropin secretions in human subjects
1995
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin‐dependent diabetes mellitus
1997
Dopaminergic and cholinergic control of argininevasopressin secretion in type I diabetic men
1995
Hypoglycemia-Induced Arginine Vasopressin and Oxytocin Release Is Mediated by Glucoreceptors Located Inside the Blood-Brain Barrier
1992
The Growth Hormone Response to Thyrotropin-Releasing Hormone in Insulin-Dependent Diabetics Involves a Cholinergic Mechanism*
1984
Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
1999
Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects
1984
Influence of Hypothalamus on Glucose Utilization by Adipose Tissue of Normal Rats
1980